secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioCorRx Inc. (BICX)
CIK:        0001443863
Form:       8-K
Filed at:   2026-09-04T13:53:58+00:00
Accession:  0001477932-26-005416
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

BioCorRx director Kate Beebe DeVarney resigns from board effective Aug 31, 2026
-------------------------------------------------------------------------------

- Kate Beebe DeVarney, Ph.D. resigned from BioCorRx board effective August 31, 2026.
- Resignation not due to any disagreement with company or subsidiary BioCorRx Pharmaceuticals.
- No replacement named in filing; board size reduced accordingly.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1443863/000147793226005416/0001477932-26-005416-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1443863/000147793226005416/bicx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-26-005416

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer